Our expert leadership team is dedicated to developing world-class antimicrobials
With over 100 years of combined pharmaceutical industry experience, our leadership team has the expertise to efficiently bring bisphosphocins to market.
WHAT WE DO
We develop novel antimicrobial therapies for those who need them the most
A rapid and safe topical bactericide and fungicide has the potential to save millions of lives.
HOW WE DO IT
Bacterial and fungal infections are swiftly eliminated directly at the site of infection
Bisphosphocins rapidly kill bacteria and fungi by depolarizing microbial cell membranes, leading to cell death within minutes.
Addressable Patient Populations (US)
1800000
Chronic Diabetic Foot Ulcers (cDFU)
65000
Undisclosed Indication
450000
Catheter-related UTI
30000
Cystic Fibrosis (CF)
Stock News Now
Published on Feb 23, 2018
SNNLive spoke with Steve Parkinson, President and CEO of Lakewood-Amedex, Inc., a private company, at the BIO CEO & Investor Conference 2018 in New York City, NY.